Texas Case Summaries
Federal Enforcement »

Raiffeisen Kapitalanlage-Gesellschaft v. Elzayat — Court vacates § 1782 discovery order and quashes subpoenas

Reported / Citable

Case
Raiffeisen Kapitalanlage-Gesellschaft mbH, et al. v. Elzayat
Court
U.S. District Court for the Western District of Texas
Judge
Andrew Davis
Date Decided
October 2, 2026
Docket No.
1:26-cv-00232
Topics
Section 1782; Foreign discovery; Securities litigation; Subpoenas

Background

Institutional investors sought discovery under 28 U.S.C. § 1782 for a contemplated Dutch securities action against Koninklijke Philips N.V. (KPNV). The investors alleged that KPNV failed to make proper disclosures concerning Respironics sleep-apnea devices whose foam could degrade and allegedly endanger users. They obtained an ex parte order permitting document and deposition subpoenas to Dr. Hisham Elzayat, Respironics’ former U.S. medical director of patient safety.

Elzayat moved to vacate the order and quash the subpoenas. KPNV and Philips RS North America LLC (Respironics) intervened and sought the same relief. Meanwhile, a federal court in Pennsylvania had granted the investors’ separate § 1782 application directed to Respironics, which represented that it would not challenge the application’s validity and would assert only ordinary discovery objections.

The Court’s Holding

Judge Andrew Davis granted the motions, vacated the ex parte § 1782 order, and quashed the subpoenas. The court held that the investors met § 1782’s threshold requirements: Elzayat resided in the district, the requested material was for use in reasonably contemplated Dutch litigation, and the investors were interested persons. But satisfying those prerequisites did not require the court to permit discovery.

On balance, the discretionary Intel factors favored denial. Although Dutch courts were generally receptive to U.S. judicial assistance, the requested evidence was available from Respironics and could be obtained through Dutch procedures. The court also concluded that the request appeared to evade a likely Dutch discovery stay connected to potential Enterprise Chamber inquiry proceedings. Finally, the subpoenas were unduly burdensome and duplicative because Respironics possessed the requested documents and prior Elzayat deposition transcripts, and the investors could not identify material uniquely available from Elzayat.

Key Takeaways

  • Meeting § 1782’s statutory requirements does not entitle an applicant to discovery; courts retain broad discretion under the Intel factors.
  • Discovery from a former employee may be denied when the corporate custodian has the same materials and is available through another § 1782 proceeding.
  • A § 1782 request may weigh against relief when it seeks to obtain discovery before a likely foreign-court stay would permit it.

Why It Matters

The decision underscores that § 1782 is not a mechanism for obtaining duplicative discovery from peripheral witnesses when the principal corporate source is available. Applicants pursuing evidence for foreign litigation should explain what information is uniquely held by the U.S. target and disclose foreign proceedings that may affect the timing or propriety of discovery.

It also illustrates how an ex parte § 1782 order remains subject to meaningful reconsideration once the subpoena recipient and affected parties appear and develop the factual record.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top